Additional file 2.

Figure S1. Combined treatment with rapamycin and bortezomib inhibits SMMC7721 proliferation. (A) Proliferation of SMMC7721 cells was evaluated by using Cell Counting Kit-8 (CCK-8) at indicated time points. (B) SMMC7721 cells were treated with rapamycin (10 ng/ml), bortezomib (100 nM) or both agents. Cell cycle analysis was carried out after 24 h. One representative experiment of three is shown.

Format: TIFF Size: 463KB Download file

Wang et al. BMC Cancer 2012 12:166   doi:10.1186/1471-2407-12-166